Yvonne Jongejan: Allele-Selective Silencing Therapy for VWD and Thrombotic Disorders
Yvonne Jongejan, Postdoctoral researcher at Leiden University Medical Center, reposted from RPTH Journal on LinkedIn:
”A nice overview in RPTH of the work Annika de Jong, Noa Linthorst, Isabel Bär, Jeroen Eikenboom and myself have done and are still doing to develop an allele-selective silencing therapy for von Willebrand disease and thrombotic disorders.”
Quoting RPTH Journal‘s post about a recent article by Jeroen Eikenboom et al:
”What if the future of VWF therapy is not replacing the protein, but silencing the wrong allele?
This RPTH State-of-the-Art review highlights allele-selective VWF silencing: a precision siRNA strategy designed to switch off only one VWF allele.
For dominant-negative VWD, this could remove mutant VWF and restore healthier multimer formation. For thrombotic disorders linked to high VWF, it may offer a controlled way to lower VWF without pushing patients into bleeding risk.
One allele. Two clinical directions. A new precision-medicine angle for VWF biology.”
Title: Allele-selective von Willebrand factor silencing
Authors: Jeroen Eikenboom, Noa Linthorst, Yvonne Jongejan
Stay updated on all scientific advances with Hemostasis Today.
-
May 27, 2026, 17:51Nita Radhakrishnan: Post Graduate Institute of Child Health Receives WFH Data Quality Certification for Excellence
-
May 27, 2026, 17:51Fiona Robinson: What exactly Are Rebalancing Agents for Bleeding Aisorders?
-
May 27, 2026, 17:14Khurram Nasir: Can Earlier LDL-C Lowering Change the Trajectory of Cardiovascular Disease?
-
May 27, 2026, 16:58Catherine Moran: Important Step Forward as 1st WHO Resolution on Stroke Gets Adopted at WHA79
-
May 27, 2026, 16:08Heghine Khachatryan: Thrombosis in Oncology Remains a Major Healthcare Burden
-
May 27, 2026, 16:00Revealing Critical Gaps in Hemophilia Diagnosis and Access to Care in India – WFH
-
May 27, 2026, 16:00Melissa Hollo: Women Deserve Proactive Care, Not Reactive Care
-
May 27, 2026, 15:59Piotr Czempik: First Report of ROTEM Findings in Triple-Positive APS and Hageman Anomaly
-
May 27, 2026, 15:59Sara Trompeter: Improving Transfusion Safety Through Advanced Blood Matching in SCD